Nanoparticle Delivery of Antisense Oligonucleotides and Their Application in the Exon Skipping Strategy for Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticle Delivery of Antisense Oligonucleotides and Their Application in the Exon Skipping Strategy for Duchenne Muscular Dystrophy

Published:2014-02 Issue:1 Volume:24 Page:87-100
ISSN:2159-3337
Container-title:Nucleic Acid Therapeutics
language:en
Short-container-title:Nucleic Acid Therapeutics

Author:

Falzarano Maria Sofia¹,Passarelli Chiara¹²,Ferlini Alessandra¹

Affiliation:

1. Section of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

2. Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/nat.2013.0450

Reference95 articles.

1. Overview on AON Design

2. Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications

3. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis

4. Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo evaluation of the redox alteration in Duchenne muscular dystrophy in mdx mice using dynamic nuclear polarization magnetic resonance imaging;2024-06-06

2. Alternative therapeutic strategies to treat antibiotic-resistant pathogens;Nature Reviews Microbiology;2023-12-11

3. Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD;Journal of Nanobiotechnology;2023-08-29

4. The Current Status of Antisense Gene Therapies for Bacteria-caused Diseases Challenges and Opportunities;Current Pharmaceutical Design;2023-02

5. Progress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics;Genes;2023-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3